Accordingly, we demonstrated that the relative proportion of CD27+CD28+ Temra inversely correlates with the number of CD8+ TILs and tumor mutation burden (TMB), known to affect the generation of neoantigens and the number of tumor-reactive CD8+ TILs. Here, CD28 is linked to neoplasm.